Stock listing
An2 Therapeutics, Inc.
Selected listing: ANTX · NASDAQ · USD · US
An2 Therapeutics, Inc. (NASDAQ:ANTX), Health Technology. Latest release Sep 28, 2026: AN2 Therapeutics Announces Extension of Funding for Tuberculosis…
- Ticker
- NASDAQ:ANTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About An2 Therapeutics, Inc.
An2 Therapeutics, Inc. is a public company trading under the ticker ANTX in the American market. An2 Therapeutics focuses on developing innovative therapies to address unmet medical needs.
Latest news from An2 Therapeutics, Inc.
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
September 28, 2026
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
September 16, 2026
AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
August 31, 2026
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
August 24, 2026
AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights
August 11, 2026
Research An2 Therapeutics, Inc.
An2 Therapeutics, Inc. company profile
View the public company page for An2 Therapeutics, Inc. on 6ix.
An2 Therapeutics, Inc. news
Read company news and market updates connected to An2 Therapeutics, Inc..
An2 Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for An2 Therapeutics, Inc..